Cargando…

Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy

OBJECTIVE: Uterine serous carcinoma (USC) is an aggressive type 2 endometrial cancer. Data on prognostic factors for patients with early-stage USC without adjuvant therapy are limited. This study aims to assess the baseline recurrence risk of early-stage USC patients without adjuvant treatment and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tate, Keisei, Yoshida, Hiroshi, Ishikawa, Mitsuya, Uehara, Takashi, Ikeda, Shun-ichi, Hiraoka, Nobuyoshi, Kato, Tomoyasu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920218/ https://www.ncbi.nlm.nih.gov/pubmed/29533019 http://dx.doi.org/10.3802/jgo.2018.29.e34

Ejemplares similares

Spontaneous ureteral rupture during concurrent chemoradiotherapy in a woman with uterine cervical cancer
por: Ikeda, Shun-ichi, et al.
Publicado: (2015)

Metachronous occurrence of two different histological subtypes of endometriosis-related neoplasms
por: Uehara, Takashi, et al.
Publicado: (2018)

Prognostic impact of intraoperative peritoneal cytology in interval debulking surgery for pelvic high‐grade serous carcinoma
por: Kojima, Naoki, et al.
Publicado: (2019)

Serum microRNA profile enables preoperative diagnosis of uterine leiomyosarcoma
por: Yokoi, Akira, et al.
Publicado: (2019)

Tumor‐associated CD204(+) M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma
por: Kawachi, Asuka, et al.
Publicado: (2018)

Identifying selection criteria for non‐radical hysterectomy in FIGO stage IB cervical cancer
por: Kasamatsu, Takahiro, et al.
Publicado: (2019)

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
por: Yoneoka, Yutaka, et al.
Publicado: (2018)

A rare case of recurrent ovarian cancer presenting as a round ligament metastasis
por: Togami, Shinichi, et al.
Publicado: (2011)

Brain Metastases from Uterine Cervical and Endometrial Cancer
por: Kato, Mayumi Kobayashi, et al.
Publicado: (2021)

Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients
por: Kato, Mayumi Kobayashi, et al.
Publicado: (2021)

The Impact of Adjuvant Management Strategies on Outcomes in Women With Early Stage Uterine Serous Carcinoma
por: Cook, Andrew, et al.
Publicado: (2021)

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
por: Lefebvre, Manon, et al.
Publicado: (2023)

Baseline risk of recurrence in stage I–II endometrial carcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2018)

Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
por: Yoneoka, Yutaka, et al.
Publicado: (2019)

Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
por: Uehara, Takashi, et al.
Publicado: (2020)

Combined modality therapy in the adjuvant treatment of uterine serous carcinoma
por: Block, Alec M., et al.
Publicado: (2016)

Evaluation of adjuvant therapy in women with uterine papillary serous cancer
por: Al Husaini, Hamed, et al.
Publicado: (2012)

Malignant struma ovarii presenting with follicular carcinoma: A case report with molecular analysis
por: Tsukada, Takafumi, et al.
Publicado: (2019)

Endometrial cancer arising after complete remission of uterine malignant lymphoma: A case report and mutation analysis
por: Kuno, Ikumi, et al.
Publicado: (2019)

Integrated extracellular microRNA profiling for ovarian cancer screening
por: Yokoi, Akira, et al.
Publicado: (2018)

A combination of circulating miRNAs for the early detection of ovarian cancer
por: Yokoi, Akira, et al.
Publicado: (2017)

Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer
por: Yokoi, Akira, et al.
Publicado: (2017)

Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer
por: Donovan, Elysia, et al.
Publicado: (2018)

Pneumonia without Respiratory Symptoms
por: Ishikawa, Kazuhiro, et al.
Publicado: (2020)

Management of Women with Surgically Staged 1 Uterine Papillary Serous Cancer
por: Elit, Laurie, et al.
Publicado: (2011)

Stage III uterine serous carcinoma: modern trends in multimodality treatment
por: Li, Jessie Y., et al.
Publicado: (2020)

Combined Adjuvant Chemotherapy and Radiation Therapy Improves Disease-Free Survival for Uterine Serous Cancer
por: Arden, Jessica D., et al.
Publicado: (2020)

Clear Cell Carcinoma of the Cervix With OHVIRA Syndrome: A Rare Case Report
por: Tanase, Yasuhito, et al.
Publicado: (2021)

Central serous chorioretinopathy with and without steroids: A multicenter survey
por: Araki, Takashi, et al.
Publicado: (2019)

How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
por: Murakami, Naoya, et al.
Publicado: (2022)

The baseline recurrence risk of patients with intermediate-risk cervical cancer
por: Yoneoka, Yutaka, et al.
Publicado: (2021)

Variations in Procedures for Ureterolysis with Sharp Dissection in Minimally Invasive Hysterectomy
por: Tanase, Yasuhito, et al.
Publicado: (2022)

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
por: Jeans, Elizabeth B, et al.
Publicado: (2021)

Extracellular microRNA profiling for prognostic prediction in patients with high‐grade serous ovarian carcinoma
por: Yoshida, Kosuke, et al.
Publicado: (2021)

Reconsideration of Sharp Dissection in Gynecological Surgery
por: Tanase, Yasuhito, et al.
Publicado: (2023)

PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer
por: Jones, Wendell, et al.
Publicado: (2022)

Pathogenesis and Clinical Management of Uterine Serous Carcinoma
por: Zhang, Li, et al.
Publicado: (2020)

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
por: Santin, A D, et al.
Publicado: (2005)

High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma
por: Damast, Shari, et al.
Publicado: (2015)

Comprehensive pelvic and paraaortic lymphadenectomy in patients with apparently early stage uterine serous carcinoma – an anachronism?
por: Emons, Günter
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2e3pvismrbhgctkbbe3cnkj4sb